68Ga-FAPI-04 PET/CT has high diagnostic efficacy in Tg-positive and Tg-negative differentiated thyroid cancer
PLOS One · 2026
DOI: 10.1371/journal.pone.0355343 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Lixian Mou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Thyroid Neoplasms, Thyroglobulin. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Affiliated Hospital of Southwest Medical University.
Abstract (Originalsprache)
Background
Thyroglobulin (Tg) is a standard biomarker for monitoring differentiated thyroid carcinoma (DTC) after radioiodine therapy, yet its reliability is compromised by false-positive and false-negative results. This study aimed to evaluate the diagnostic performance of 68 Ga-FAPI-04 PET/CT, an emerging imaging modality, for detecting recurrence and metastasis in DTC patients, regardless of their Tg status.
Methods
This retrospective study included patients with suspected or confirmed metastatic DTC who underwent 68 Ga-FAPI-04 PET/CT between October 2022 and May 2025. All participants underwent 68 Ga-FAPI-04 PET/CT and Tg testing, with histopathology or clinical follow-up as the reference standard. The sensitivity, specificity, and accuracy of both methods were compared. Quantitative analysis was performed using the target-to-background ratio (TBR).
Results
Among 99 patients in a TSH-suppressed state, 68 Ga-FAPI-04 PET/CT demonstrated superior diagnostic accuracy (95.96%) compared to Tg testing (91.92%). In 48 TSH-stimulated patients, PET/CT maintained perfect accuracy (100%), outperforming Tg (97.92%). Notably, PET/CT successfully identified metastatic lesions in eight Tg-negative patients, primarily lymph node metastases. Using the mediastinum as a background for TBR calculation further enhanced the diagnostic efficacy for lymph node metastases, with the optimal threshold being 1.428, and achieving an accuracy and true positive rate of 0.98.
Conclusion
68 Ga‑FAPI‑04 PET/CT exhibits high accuracy for diagnosing recurrence and metastasis in DTC, and importantly can identify lesions in Tg‑negative patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
- Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, China.
- Laboratory for Targeted Radiopharmaceuticals Creation, Luzhou, Sichuan, China.
- Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China.
- Department of General Practice, Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
- Department of Pathology, Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
ORCID-Profile: Lixian Mou, Wei Wang
Förderung
- Affiliated Hospital of Southwest Medical University
Zitieren
APA
Mou, L., Zhang, T., Zhang, X., Zhou, J., Chen, Y., & Wang, W. (2026). 68Ga-FAPI-04 PET/CT has high diagnostic efficacy in Tg-positive and Tg-negative differentiated thyroid cancer. PLOS One. https://doi.org/10.1371/journal.pone.0355343
Vancouver
Mou L, Zhang T, Zhang X, Zhou J, Chen Y, Wang W. 68Ga-FAPI-04 PET/CT has high diagnostic efficacy in Tg-positive and Tg-negative differentiated thyroid cancer. PLOS One. 2026. doi:10.1371/journal.pone.0355343
BibTeX
@article{Mou2026,
author = {Mou, Lixian and Zhang, Ting and Zhang, Xiaoling and Zhou, Jian and Chen, Yue and Wang, Wei},
title = {68Ga-FAPI-04 PET/CT has high diagnostic efficacy in Tg-positive and Tg-negative differentiated thyroid cancer},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0355343}
}
EUVIMED